A Retrospective Study from a Single Center in China to Develop a Nomogram to Predict One-Year Mortality in Patients with End-Stage Renal Disease Who Are Receiving Hemodialysis

19 July 2022: Clinical Research

Wubin Yao ^AEG , Yan Shen ^AE , Huaxing Huang ^ABCD , Hongli Yang ^BCD , Xingxing Fang ^BCD , Lianglan Shen ^AE*

DOI: 10.12659/MSM.936092

Med Sci Monit 2022; 28:e936092

Table 3 The predictive ability of nomogram for different subgroup population.

Population	n (%)	C-index	S. E	95% CI
Total	299 (100.00)	0.729	0.028	0.674–0.784
Sex
Male	174 (58.19)	0.733	0.033	0.668–0.798
Female	125 (41.81)	0.718	0.052	0.616–0.820
Primary diseases
Chronic glomerulonephritis	108 (36.12)	0.839	0.044	0.753–0.925
Diabetic nephropathy	96 (32.11)	0.617	0.059	0.501–0.733
Hypertensive nephropathy	44 (14.72)	0.749	0.077	0.598–0.900
Polycystic kidney	22 (7.36)	0.713	0.092	0.533–0.893
Other^*	29 (9.70)	0.784	0.065	0.657–0.911
Hypertension
No	25 (8.36)	0.898	0.039	0.822–0.974
Yes	274 (91.64)	0.701	0.032	0.638–0.764
Type of diabetes
Normal	162 (54.18)	0.775	0.037	0.702–0.848
Type I	4 (1.34)	–
Type II	133 (44.48)	0.678	0.046	0.588–0.768
Hyperlipidemia
No	280 (93.65)	0.730	0.029	0.673–0.787
Yes	19 (6.35)	0.676	0.113	0.455–0.897
Myocardial infarction or revascularization
No	281 (93.98)	0.726	0.029	0.669–0.783
Yes	18 (6.02)	0.778	0.117	0.549–1.007
Congestive heart failure
No	239 (79.93)	0.719	0.031	0.658–0.780
Yes	60 (20.07)	0.745	0.057	0.633–0.857
Stroke
No	286 (95.65)	0.773	0.028	0.718–0.828
Yes	13 (4.35)	0.706	0.154	0.404–1.008
Peripheral vascular disease
No	295 (98.66)	0.731	0.029	0.674–0.788
Yes	4 (1.34)	–
Other cardiovascular diseases
No	288 (96.32)	0.729	0.029	0.672–0.786
Yes	11 (3.68)	0.792	0.091	0.614–0.970
History of cancer
No	285 (95.32)	0.724	0.029	0.667–0.781
Yes	14 (4.68)	0.796	0.089	0.622–0.970
^* Other – included systemic lupus erythematosus, gouty nephropathy, obstructive nephropathy, ANCA-associated systemic vasculitis; CI – confidence interval.